The subgroup of GATA3low ETP-ALL is molecularly and clinically relevant as it lacks T lineage commitment in favor of a sustained myeloid gene expression signaling and a high rate of FLT3 mutations. Here, FLT3 is linked to acute lymphoblastic leukemia.